Existing Patented Drugs

Once the benchmark prices for a patented drug product are established, the patented medicine prices Guidelines considers that drug product to be 'existing.'

The Consumer Price Index and international pricing impact the price of a drug in Canada throughout the patented life of the product. As a result, manufacturers need to closely monitor rate changes to ensure compliance with the PMPRB Regulations.

The Brogan Inc. Price Regulation Consulting team will conduct quarterly price monitoring for your products to recognize opportunities and ensure compliance, thereby avoiding penalties.

For more information, please contact Brogan Inc. Price Regulation Consulting team at 613.599.0711 ext 255.